FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity.

Haematologica

Volumn 92, Issue 11, 2007, Pages

  Buchler, T ^a   Bomanji, J ^b   Lee, S M ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; DACARBAZINE; DIAGNOSTIC AGENT; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; VINBLASTINE;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HODGKIN DISEASE; HUMAN; LUNG; METHODOLOGY; MIDDLE AGED; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; FEMALE; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; LUNG; MIDDLE AGED; PNEUMONIA; POSITRON-EMISSION TOMOGRAPHY; VINBLASTINE;

MLCS; MLOWN;

EID: 53549124630     PISSN: None     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.11856     Document Type: Article

References (0)